文献速递胰腺与胆道疾病消化内镜消化道出血

胰腺包裹性坏死内镜下坏死组织清除术中出血的预测与管理:大样本回顾性队列研究

Prediction and management of bleeding during endoscopic necrosectomy for pancreatic walled-off necrosis: results of a large retrospective cohort at a tertiary referral center.
PubMed 文献 · Gastrointest Endosc · 2021-10-19

该研究回顾性分析151例胰腺包裹性坏死患者共536次内镜下坏死组织清除术,术中出血发生率为每次操作5.2%、每例患者11.9%。内镜下发现腔内有血管是出血的强预测因素,术前输血量较多的患者更需要介入放射学止血。

要点

  • 内镜下坏死组织清除术每次操作出血风险5.2%,每例患者出血风险11.9%。
  • 内镜下发现腔内有血管是术中出血的强预测因素。
  • 术前输血量较多的患者可能需要更早进行介入放射学干预。

核心结论

  • 胰腺包裹性坏死内镜下坏死组织清除术的出血风险为每次操作5.2%、每例患者11.9%。
  • 内镜下发现腔内有血管可预测术中出血。
  • 术前需要更多输血的患者可能需要更早的介入放射学干预。

研究设计与样本

  • 回顾性队列研究,纳入2014年6月至2020年10月期间151例接受内镜下坏死组织清除术的胰腺包裹性坏死患者,共536次操作。
  • 记录人口学特征、合并症、合并用药及胰腺炎病因,比较术前、术中、术后临床变量。
  • 使用χ2检验和独立t检验进行统计分析。

主要发现

  • 术中出血发生于28次操作(5.2%),涉及18例患者(11.9%)。
  • 8例患者(10次操作)尝试内镜下止血。
  • 8例患者(10次操作)接受介入放射学治疗。
  • 血小板减少(P = .006)和肝硬化(P = .049)与术中出血相关,但血小板减少仅见于1例患者。
  • 内镜下发现腔内有血管与出血相关(P < .001),多因素分析中仍为强预测因素(P < .001),而肝硬化不再显著。

临床怎么用

  • 内镜下坏死组织清除术中应关注腔内有血管的发现,以预测出血风险。
  • 术前输血量较多的患者可考虑更早启动介入放射学干预。

局限性

  • 回顾性队列研究设计。
  • 单中心三级转诊中心数据。
  • 血小板减少仅见于1例患者,相关分析受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Lumen-apposing metal stents (LAMSs) provide an endoscopic method for management of walled-off necrosis (WON) and a gateway for the performance of endoscopic necrosectomy (EN). However, bleeding may occur in up to 20% of EN procedures. Predictive factors for bleeding in this patient population are unknown, and there is no agreed-on algorithm for the management of bleeding. The aim of this study was to evaluate preprocedural risk factors for bleeding in patients undergoing endoscopic drainage or EN for WON. METHODS: A retrospective cohort of patients undergoing EN for WON was reviewed. Demographics, comorbidities, concurrent medications, and etiology of pancreatitis were recorded. Pre-, peri-, and postprocedural clinical variables were compared using the χ2 test and independent t test. RESULTS: Between June 2014 and October 2020, 536 ENs were performed in 151 patients. Intraprocedural bleeding occurred during 28 procedures (5.2%) in 18 patients (11.9%). Endoscopic hemostasis was attempted in 8 patients (10 procedures). Eight patients (10 procedures) in total were treated by interventional radiology (IR). Thrombocytopenia (P = .006) and cirrhosis (P = .049) were associated with intraprocedural bleeding, although thrombocytopenia was present in only 1 patient. Identification of a vessel within the cavity endoscopically was also associated with bleeding (P < .001). On multivariate analysis, identification of a vessel within the cavity endoscopically remained a strong predictor of bleeding (P < .001), whereas cirrhosis was no longer significant. Patients who required IR for hemostasis were transfused with significantly more blood before the procedure than patients who did not (3.4 units vs .67 units, P = .002). CONCLUSIONS: EN for WON was associated with a 5.2% per-procedure risk of bleeding and an 11.9% per-patient bleeding risk. Identification of a vessel within the cavity during endoscopy is predictive of bleeding during EN. Patients who require more transfusions before endoscopy may require earlier intervention by IR.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Holmes I, Shinn B, Mitsuhashi S, et al. Prediction and management of bleeding during endoscopic necrosectomy for pancreatic walled-off necrosis: results of a large retrospective cohort at a tertiary referral center. Gastrointest Endosc. 2021. PMID: 34678298. doi:10.1016/j.gie.2021.10.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。